Asthma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
Children and teenagers (ages 6–18):
- Children and teenagers between 6 and 18 years old at the time of joining the trial
- Asthma has been formally diagnosed by a doctor
- Other conditions that could explain the symptoms have been ruled out
- The child has been taking their medication as prescribed and has been shown the correct way to use their inhaler
- Breathing tests show either that the airways open up significantly after using a reliever (rescue) inhaler, or that the airways react strongly to certain triggers during a supervised breathing test
- The child is on a high level of asthma treatment, which may include: high-dose inhaled steroids alone, medium-to-high dose inhaled steroids combined with other long-term asthma medicines (such as long-acting relievers or leukotriene modifiers), or has been taking steroid tablets for 3 months or more
- Asthma has been poorly controlled in the past year, shown by: symptoms or use of a reliever inhaler 3 or more times per week, any limitation of activities due to asthma, any asthma symptoms during the night, at least one severe flare-up in the past year requiring steroid tablets for 3 or more days or a hospital stay, or reduced lung function shown on breathing tests
- A parent or legal guardian has provided written consent for the child to take part
Adults:
- Adults on a high level of asthma treatment, which may include: high-dose inhaled steroids combined with other long-term asthma medicines, steroid tablets taken for 3 or more months, or treatment with a biological medicine (monoclonal antibody injection)
- Adults on a medium-to-high dose of inhaled steroids combined with other long-term asthma medicines, AND whose asthma is still poorly controlled — shown by: symptoms or reliever use 3 or more times per week, activity limitations due to asthma, any night-time symptoms, at least one severe flare-up in the past year requiring steroid tablets for 3 or more days, or lung function below 80% of what is expected for that person
Who may not be able to join:
Children and teenagers:
- Children diagnosed with another lung condition affecting airflow or the whole body, such as cystic fibrosis or COPD (a lung condition called BPD may still be acceptable — confirm with trial site)
- Children with other lung conditions present from birth, or physical abnormalities of the lungs
- Children with other significant long-term health conditions
- Children with heart conditions present from birth or developed later that cause significant physical limitations
Note: No specific exclusion criteria were listed for adults in the source information. Confirm with the trial site whether additional exclusions apply.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +49 (0)1577-6948673
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Symptom Control
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.